Question to the Department for Environment, Food and Rural Affairs:

To ask His Majesty's Government, further to the Written Answer by Baroness Hayman of Ullock on 5 February (HL14039), (1) when the regulatory review of the AVM‑GSL status of products containing fipronil and imidacloprid will be completed, and (2) whether input from vets and scientists external to the Veterinary Medicines Directorate will be consulted and contribute to the review.

The Veterinary Medicines Directorate (VMD) is undertaking a review of the AVM‑GSL status of veterinary medicines containing fipronil and imidacloprid, and further details on the review will be published in the coming weeks. A completion date cannot yet be provided as this is dependent on finalising the process and associated milestones.

The review will include a consultative process, drawing on evidence and input from all stakeholders. All decisions will be based on robust scientific assessment, with animal health and welfare remaining paramount throughout the review.